Palliative physician supports neuraxial analgesia for cancer pain

10/23/2012 | Medscape (free registration)

Neuraxial analgesia is an effective palliative care option for cancer patients with refractory pain or opioid toxicity, and it can be continued after discharge, according to Dr. Aynharan Sinnarajah, an intensive palliative care physician from Alberta, Canada. He told a palliative care conference that fentanyl and methadone are commonly used instead of first-line opioids and that patients often are on their third or fourth opioid drug before neuraxial analgesia is considered.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ